22nd Century Group, Inc. (XXII)
| Previous Close | 1.7800 |
| Open | 1.7700 |
| Bid | 1.6900 x 1800 |
| Ask | 1.7000 x 800 |
| Day's Range | 1.6850 - 1.7700 |
| 52 Week Range | 1.4200 - 5.2500 |
| Volume | |
| Avg. Volume | 1,529,437 |
| Market Cap | 278.89M |
| Beta (5Y Monthly) | 2.02 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.2270 |
| Earnings Date | Aug 03, 2022 - Aug 08, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.50 |
- GlobeNewswire
22nd Century Group (Nasdaq: XXII) Announces John J. Miller Joins Its Tobacco Business
Highly Regarded for His Extensive Sales and Marketing Experience in the Tobacco Industry Expands and Further Strengthens the Company’s Team of Tobacco Industry Experts BUFFALO, N.Y., May 23, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, today announced John J. Miller will direct the growth and achieve the ful
- GlobeNewswire
22nd Century Group (Nasdaq: XXII) Begins Integration of GVB Biopharma, Creating a Complete, Robust Hemp/Cannabis Platform
Complete Hemp/Cannabis Solution from Receptor Science and Plant Genetics to Final Ingredients and CDMOConsistent, Reliable, High-Quality Cannabinoids and Cannabinoid Infused Products for ConsumersAcquisition Immediately Accretive; Will Double 22nd Century Revenue BUFFALO, N.Y., May 18, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced pl
- GlobeNewswire
22nd Century Group (Nasdaq: XXII) Acquires GVB Biopharma, a Leading Hemp/Cannabis Company
Provides Transformational Platform to Rapidly Grow Hemp/Cannabis FranchiseTransaction Immediately Accretive and Will Double Company’s Total RevenueAdds Significant Commercial Scale to Existing Hemp/Cannabis FranchiseGVB Biopharma has Achieved Strong Growth and Leading Market Share in Hemp-Derived Active Ingredients BUFFALO, N.Y., May 13, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving human health with reduced
